Companies › ANIP

ANI PHARMACEUTICALS INC (ANIP)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001023024 · EDGAR filings · Updated 2026-07-27

ANI PHARMACEUTICALS INC (ANIP) has reported institutional ownership of 103.6%, with 277 institutional managers holding positions valued at $1.79B per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01).

Filings this week (1)

• 2026-07-27 — SCHEDULE 13G/A filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-21 — Insider transaction reported (Form 4)
• 2026-07-17 — Employee-plan registration (S-8) filed
• 2026-07-14 — Insider transaction reported (Form 4)
• 2026-07-07 — Notice of proposed sale filed (Form 144)
• 2026-07-06 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ANI PHARMACEUTICALS INC has 277 institutional holders and institutional ownership of 103.6%.

Insider activity

Insiders reported 111 transactions (0 buys, 54 sells) across 15 reporting insiders, with a net reported value of −$43.4M.

Data flags from SEC filings

Related companies

SIONNA THERAPEUTICS INC (SION) · NURIX THERAPEUTICS INC (NRIX) · ADDUS HOMECARE CORP COM (ADUS) · VERICEL CORP COM (VCEL) · OCULAR THERAPEUTIX INC (OCUL) · PEDIATRIX MEDICAL GROUP INC (MD)